dapi has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies
DAPI: RN given refers to parent cpd.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, Z | 1 |
| Nyberg, R | 1 |
| Wu, Y | 1 |
| Bernard, B | 1 |
| Redmond, WL | 1 |
| Carlsson, A | 1 |
| Nair, VS | 1 |
| Luttgen, MS | 1 |
| Keu, KV | 1 |
| Horng, G | 1 |
| Vasanawala, M | 1 |
| Kolatkar, A | 1 |
| Jamali, M | 1 |
| Iagaru, AH | 1 |
| Kuschner, W | 1 |
| Loo, BW | 1 |
| Shrager, JB | 1 |
| Bethel, K | 1 |
| Hoh, CK | 1 |
| Bazhenova, L | 1 |
| Nieva, J | 1 |
| Kuhn, P | 1 |
| Gambhir, SS | 1 |
| Schalper, KA | 1 |
| Brown, J | 1 |
| Carvajal-Hausdorf, D | 1 |
| McLaughlin, J | 1 |
| Velcheti, V | 1 |
| Syrigos, KN | 1 |
| Herbst, RS | 1 |
| Rimm, DL | 1 |
| Tseng, SJ | 1 |
| Liao, ZX | 1 |
| Kao, SH | 1 |
| Zeng, YF | 1 |
| Huang, KY | 1 |
| Li, HJ | 1 |
| Yang, CL | 1 |
| Deng, YF | 1 |
| Huang, CF | 1 |
| Yang, SC | 1 |
| Yang, PC | 1 |
| Kempson, IM | 1 |
| Sauvat, A | 1 |
| Wang, Y | 1 |
| Segura, F | 1 |
| Spaggiari, S | 1 |
| Müller, K | 1 |
| Zhou, H | 1 |
| Galluzzi, L | 1 |
| Kepp, O | 1 |
| Kroemer, G | 1 |
| Koryllou, A | 1 |
| Patrinou-Georgoula, M | 1 |
| Troungos, C | 1 |
| Pletsa, V | 1 |
| Wu, RW | 1 |
| Yow, CM | 1 |
| Wong, CK | 1 |
| Lam, YH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Window Trial of 5-Azacytidine or Nivolumab or Combination Nivolumab Plus 5-Azacytidine in Resectable HPV-Associated Head and Neck Squamous Cell Cancer[NCT05317000] | Early Phase 1 | 50 participants (Anticipated) | Interventional | 2023-03-23 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for dapi and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; B7-H1 Antigen; Biomarkers, Tumor; Breast Ne | 2021 |
Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Emboli | 2014 |
Objective measurement and clinical significance of TILs in non-small cell lung cancer.
Topics: Antigens, CD20; Carcinoma, Non-Small-Cell Lung; CD3 Complex; CD8 Antigens; Confounding Factors, Epid | 2015 |
Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumour.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dimethyl Sulfoxide; Endosomes; | 2015 |
Quantification of cellular viability by automated microscopy and flow cytometry.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Benzimidazoles; Carbocyanines; Carcinoma, Non-Small-Cell | 2015 |
Cell death induced by N-methyl-N-nitrosourea, a model S(N)1 methylating agent, in two lung cancer cell lines of human origin.
Topics: Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Nu | 2009 |
Photodynamic therapy (PDT) - Initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines.
Topics: Aminolevulinic Acid; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell | 2011 |